Monoclonal antibody SC104 and derivative thereof specifically binding to a sialyltetraosyl carbohydrate as a potential anti-tumor therapeutic agent

Details for Australian Patent Application No. 2005240837 (hide)

International Classifications

Event Publications

23 November 2006 PCT application entered the National Phase

PCT publication WO2005/108430 Priority application(s): WO2005/108430

24 April 2008 Assignment before Grant

Scancell Limited The application has been assigned to Arana Therapeutics Limited

19 August 2010 Alteration of Name

The name of the applicant has been altered to Cephalon Australia Pty Ltd

11 November 2010 Application Accepted

Published as AU-B-2005240837

10 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.